GlaxoSmithKline has selected Weybridge in Surrey as the location for its consumer healthcare global HQ.
The independent division will house an innovation centre made up of research and development laboratories, and will be home to 1,400 employees.
The campus will open at the end of 2024, subject to planning approvals.